• FDA Approves HETLIOZ for Nighttime Sleep Disturbances in Smith-Magenis Syndrome americanpharmaceuticalreview
    December 22, 2020
    Vanda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with nighttime sleep disturbances associated with ...
  • Vanda Announces Positive Study Results for Hetlioz americanpharmaceuticalreview
    December 11, 2018
PharmaSources Customer Service